Crossject

Crossject is a specialty pharma company developing a portfolio of drugs for use in emergency situations like severe migraines, epilepsy, temporary paralysis, anaphylactic shock, overdoses, acute asthma with its ZENO device.In February 2018, the company announced allotment of warrants to its existing share holders at one warrant per share at a price of EUR 4.50 (US $ 5.5) per share, at that time it also issued convertible bonds of EUO 5.25 million (US $ 6.43 million)